New hope for pancreatic cancer: EXPAND trial targets limited metastases

NCT ID NCT06593431

First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 31 times

Summary

This phase 3 trial tests whether a multi-disciplinary treatment plan can help people with pancreatic cancer that has spread to only a few other places in the body live longer without the disease getting worse. About 80 adults with this condition will receive either standard care or a coordinated approach involving multiple types of treatment. The study aims to see if this combined strategy improves survival and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cooper Hospital University Medical Center

    RECRUITING

    Camden, New Jersey, 08103, United States

    Contact Email: •••••@•••••

    Contact

  • Cooper Hospital University Medical Center

    RECRUITING

    Voorhees Township, New Jersey, 08043, United States

    Contact Email: •••••@•••••

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.